These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8250970)

  • 1. Alteration of the phosphorylation state of p34cdc2 kinase by the flavone L86-8275 in breast carcinoma cells. Correlation with decreased H1 kinase activity.
    Worland PJ; Kaur G; Stetler-Stevenson M; Sebers S; Sartor O; Sausville EA
    Biochem Pharmacol; 1993 Nov; 46(10):1831-40. PubMed ID: 8250970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition with reversible cell cycle arrest of carcinoma cells by flavone L86-8275.
    Kaur G; Stetler-Stevenson M; Sebers S; Worland P; Sedlacek H; Myers C; Czech J; Naik R; Sausville E
    J Natl Cancer Inst; 1992 Nov; 84(22):1736-40. PubMed ID: 1279187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.
    Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ
    Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent inhibition of CDC2 kinase activity by the flavonoid L86-8275.
    Losiewicz MD; Carlson BA; Kaur G; Sausville EA; Worland PJ
    Biochem Biophys Res Commun; 1994 Jun; 201(2):589-95. PubMed ID: 8002990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin B targets p34cdc2 for tyrosine phosphorylation.
    Meijer L; Azzi L; Wang JY
    EMBO J; 1991 Jun; 10(6):1545-54. PubMed ID: 1709096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phorbol ester TPA rapidly prevents activation of p34cdc2 histone H1 kinase and concomitantly the transition from G2 phase to mitosis in synchronized HeLa cells.
    Barth H; Kinzel V
    Exp Cell Res; 1994 Jun; 212(2):383-8. PubMed ID: 8187833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cis-diamminedichloroplatinum(II) inhibits p34cdc2 protein kinase in human lung-cancer cells.
    Nishio K; Fujiwara Y; Miyahara Y; Takeda Y; Ohira T; Kubota N; Ohta S; Funayama Y; Ogasawara H; Ohata M
    Int J Cancer; 1993 Oct; 55(4):616-22. PubMed ID: 8406990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of p34cdc2 complex formation from phosphorylation and histone H1 kinase activity.
    Eblen ST; Fautsch MP; Burnette RJ; Snyder M; Leof EB
    Cancer Res; 1995 May; 55(9):1994-2000. PubMed ID: 7728771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement for p34cdc2 kinase is restricted to mitosis in the mammalian cdc2 mutant FT210.
    Hamaguchi JR; Tobey RA; Pines J; Crissman HA; Hunter T; Bradbury EM
    J Cell Biol; 1992 Jun; 117(5):1041-53. PubMed ID: 1533642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MPF is activated in growing immature Xenopus oocytes in the absence of detectable tyrosine dephosphorylation of P34cdc2.
    Rime H; Yang J; Jessus C; Ozon R
    Exp Cell Res; 1991 Oct; 196(2):241-5. PubMed ID: 1716585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells.
    Ling YH; el-Naggar AK; Priebe W; Perez-Soler R
    Mol Pharmacol; 1996 May; 49(5):832-41. PubMed ID: 8622633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth condition-induced precocious activation of p34cdc2 kinase inhibits the expression of developmental competence.
    Jantzen H; Schulze I
    Dev Biol; 1994 Nov; 166(1):311-22. PubMed ID: 7958455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of the synthesis and activity of the major cyclin-dependent kinases, p34cdc2, p33cdk2, and p34cdk4, during cell cycle entry and progression in normal human T lymphocytes.
    Lucas JJ; Szepesi A; Domenico J; Tordai A; Terada N; Gelfand EW
    J Cell Physiol; 1995 Nov; 165(2):406-16. PubMed ID: 7593219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A deficiency in the mechanism for p34cdc2 protein kinase activation in mouse embryos arrested at 2-cell stage.
    Aoki F; Choi T; Mori M; Yamashita M; Nagahama Y; Kohmoto K
    Dev Biol; 1992 Nov; 154(1):66-72. PubMed ID: 1426634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of cdc2 phosphorylation sites in the cdc25 phosphatase blocks initiation of M-phase.
    Izumi T; Maller JL
    Mol Biol Cell; 1993 Dec; 4(12):1337-50. PubMed ID: 7513216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The G2/M DNA damage checkpoint inhibits mitosis through Tyr15 phosphorylation of p34cdc2 in Aspergillus nidulans.
    Ye XS; Fincher RR; Tang A; Osmani SA
    EMBO J; 1997 Jan; 16(1):182-92. PubMed ID: 9009279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
    Arita Y; Buffolino P; Coppock DL
    Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dephosphorylation and activation of a p34cdc2/cyclin B complex in vitro by human CDC25 protein.
    Strausfeld U; Labbé JC; Fesquet D; Cavadore JC; Picard A; Sadhu K; Russell P; Dorée M
    Nature; 1991 May; 351(6323):242-5. PubMed ID: 1828290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of p34cdc2 protein kinase activity by phosphorylation and cyclin binding.
    Nigg EA; Gallant P; Krek W
    Ciba Found Symp; 1992; 170():72-84; discussion 84-96. PubMed ID: 1483352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of p34cdc2 kinase by cyclin A.
    Roy LM; Swenson KI; Walker DH; Gabrielli BG; Li RS; Piwnica-Worms H; Maller JL
    J Cell Biol; 1991 May; 113(3):507-14. PubMed ID: 1826688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.